Clinical trials for Idiopathic pulmonary fibrosis
100 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGPhase 1NCT05988463Dose-Escalation Study of Artesunate Patients With IPFJoseph C. Wu · PI: Joshua Mooney, MD
- RECRUITINGN/ANCT07482917Optimizing the Diagnostic Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-1 TrialHospital de Granollers · PI: Jaume Bordas-Martinez, MD, PhD
- RECRUITINGN/ANCT07486206Optimizing the Follow-Up Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-2 TrialHospital de Granollers · PI: Jaume Bordas-Martinez, MD, PhD
- RECRUITINGPhase 2NCT06241560A Study in People With Idiopathic Pulmonary Fibrosis to Test Whether Pirfenidone Influences the Amount of BI 1015550 in the BloodBoehringer Ingelheim
- RECRUITINGPhase 3NCT07201922A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary FibrosisBoehringer Ingelheim
- RECRUITINGN/ANCT07466420Study on the Efficacy of Quercetin Intake in Patients With Fibrotic Interstitial Lung Diseases.Katerina M. Antoniou · PI: Katerina M. Antoniou, MD PhD, Professor
- RECRUITINGPhase 3NCT07299695Intravenous Immunoglobulin for the Treatment of Acute Exacerbations of Idiopathic Pulmonary FibrosisArgyrios Tzouvelekis
- RECRUITINGPhase 2NCT07284459Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary FibrosisContineum Therapeutics · PI: Mudiaga O Sowho, MD, MPH
- RECRUITINGPhase 1NCT07407543A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SRN001 in Healthy Korean and Caucasian Adult MalessiRNAgen Therapeutics Inc.
- RECRUITINGPhase 3NCT07464912A Adaptive Design Clinical Trial to Evaluate the Efficacy and Safety of TDI01 Suspension in the Treatment of Idiopathic Pulmonary Fibrosis (IPF)Beijing Tide Pharmaceutical Co., Ltd
- RECRUITINGPHASE1, PHASE2NCT07464132Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related DiseasesPeking Union Medical College Hospital
- RECRUITINGPhase 1NCT07225296A Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GNS-3545 in Healthy ParticipantsGenosco Inc.
- RECRUITINGPhase 2NCT07121413A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of SV001 in Patients With Idiopathic Pulmonary FibrosisShanghai Synvida Biotechnology Co.,Ltd.
- RECRUITINGPhase 2NCT06567717Zinc and Nicotinamide Riboside for Idiopathic Pulmonary FibrosisCedars-Sinai Medical Center · PI: Tanzira Zaman, MD
- ACTIVE NOT RECRUITINGNCT07396467Clinical Outcomes and Immunotherapy in Lung Cancer With Pulmonary FibrosisThe First Affiliated Hospital with Nanjing Medical University
- RECRUITINGPhase 2NCT07192939Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Trial to Evaluate the Efficacy and Safety of HRS-9813 in Subjects With Pulmonary FibrosisGuangdong Hengrui Pharmaceutical Co., Ltd
- RECRUITINGN/ANCT07457463Evaluation of the Pulmonary Fibrosis Learning and Self-management Programme (FILIP)Insel Gruppe AG, University Hospital Bern · PI: Thimo Marcin, PHD
- RECRUITINGNCT07251725GEN-FPF: Genetic Exploration of Familial Pulmonary FibrosisFondazione IRCCS Policlinico San Matteo di Pavia
- RECRUITINGNCT07332117A Pilot Study to Assess Body Mass Composition Measurement Using BIA and Muscle Ultrasound in IPF and PPF Patients on Anti-fibrotic MedicationsRoyal Brompton & Harefield NHS Foundation Trust
- RECRUITINGPhase 1NCT07036029NAL ER IPF Respiratory Function and Safety StudyTrevi Therapeutics · PI: Chief Development Officer
- RECRUITINGPhase 2NCT06714123Senicapoc in Patients With Worsening Fibrotic Interstitial Lung DiseaseVejle Hospital · PI: Ole Hilberg, Proffesor
- RECRUITINGPhase 2NCT06736990A Phase 2 Study of CAL101 in Patients With Idiopathic Pulmonary FibrosisCalluna Pharma AS
- RECRUITINGNCT07312305Small Airways Disease Functional Assessment in Idiopathic Pulmonary Fibrosis (SWIFT-IPF)University of Milan
- RECRUITINGN/ANCT06756230Downhill Walking in IPFSaglik Bilimleri Universitesi
- RECRUITINGEarly Phase 1NCT06853145Hyperpolarized Xenon-129 MRI in Idiopathic Pulmonary FibrosisUniversity of Virginia · PI: John Kim, MD
- ACTIVE NOT RECRUITINGNCT06685874Interstitial Lung Disease Exacerbations StudyRoyal Devon and Exeter NHS Foundation Trust · PI: Michael Gibbons, MBChB
- RECRUITINGPhase 2NCT06951217An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)Avalyn Pharma Inc. · PI: Avalyn Pharma, Inc.
- ACTIVE NOT RECRUITINGNCT07048652Evaluating the Diagnostic Performance of (HRCT) in IPD Fibrosis in Suspected CasesSuperior University
- RECRUITINGN/ANCT06751069Home-based Pulmonary Rehabilitation and Health Coaching in Patients With Fibrotic Interstitial Lung DiseaseMayo Clinic · PI: Teng Moua
- RECRUITINGPhase 1NCT06821464A Trial of HRS-9813 in Healthy SubjectsGuangdong Hengrui Pharmaceutical Co., Ltd
- RECRUITINGPhase 2NCT06747923SB17170 Phase 2 Trial in IPF PatientsSPARK Biopharma
- RECRUITINGPhase 2NCT06532071Advanced Imaging for Pulmonary FibrosisPeter Caravan · PI: Sydney Montesi, MD
- ACTIVE NOT RECRUITINGNCT07139925Assessment of Self-Care in Patients With Idiopathic Pulmonary Fibrosis (IPF)Fondazione Policlinico Universitario Agostino Gemelli IRCCS · PI: Luca Richeldi
- RECRUITINGNCT07174102Radiologic Features of Rheumatoid Arthritis Interstitial Lung Disease at Chest High Resolution Computed TomographyAzienda Unita Sanitaria Locale di Piacenza
- ACTIVE NOT RECRUITINGPhase 2NCT06422884A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)Endeavor Biomedicines, Inc. · PI: Lisa Lancaster, M.D.
- RECRUITINGNCT06162884Single Time Point Prediction as Earlier Diagnosis of Progressive Pulmonary FibrosisUniversity of California, Los Angeles · PI: Samuel Weigt, MD
- RECRUITINGN/ANCT06615492Routine vs On-demand ECMO for Lung TransplantationCentre hospitalier de l'Université de Montréal (CHUM)
- ACTIVE NOT RECRUITINGNCT06485635Real-life-persistence to Antifibrotic TreatmentsBoehringer Ingelheim
- RECRUITINGNCT06909409D Vitamin and Alveolar Macrophages in Idiopathic Pulmonal FibrosisUniversity of Aarhus
- RECRUITINGN/ANCT06883448Implementation of Home Monitoring in Patients With Pulmonary FibrosisErasmus Medical Center · PI: Marlies S. Wijsenbeek-Lourens, Prof Dr
- ENROLLING BY INVITATIONN/ANCT07061873Physical Exercise Program for Adults With Diffuse Interstitial Lung Disease in a Pulmonary Rehabilitation ContextUniversidad de La Frontera
- RECRUITINGPhase 1NCT06589219Study to Assess CMR316 in Healthy Volunteers and Patients With Idiopathic Pulmonary FibrosisCalibr, a division of Scripps Research · PI: Chan Beals, MD, PhD
- ENROLLING BY INVITATIONNCT06629623Current Status of Diagnosis, Treatment and Quality of Life for Patients with Idiopathic Pulmonary FibrosisChu Hongling · PI: Hongling Chu, PhD
- RECRUITINGPhase 1NCT06482190A Study to Evaluate Safety, Tolerability and Pharmacokinetics of RSN0402 in Healthy VolunteersShenzhen Resproly Biopharmaceutical Co., Ltd
- ACTIVE NOT RECRUITINGNCT06618924Digital Modeling of Thoracic CT and Pulmonary FibrosisAssistance Publique - Hôpitaux de Paris · PI: Pierre-Yves Brillet, Pr
- RECRUITINGNCT06323876The Role of Quantitative CT and Radiomic Biomarkers for Precision Medicine in Pulmonary FibrosisUniversity of Virginia · PI: Noth Imre, MD
- RECRUITINGNCT06445686Ongoing Monitoring of Vital Signs in Patients With Idiopathic Pulmonary Fibrosis Before and After Acute Exacerbation.Biosency · PI: Stéphane JOUNEAU, MD
- ACTIVE NOT RECRUITINGPhase 2NCT05983471Efficacy and Safety of ME-015 (Suplatast Tosilate) in Cough Related to Idiopathic Pulmonary Fibrosis (COSMIC-IPF)Melius Pharma AB
- RECRUITINGPhase 2NCT05975983Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary FibrosisInSilico Medicine Hong Kong Limited
- ACTIVE NOT RECRUITINGPhase 1NCT06265532Collagen-targeted Positron Emission Tomography (PET) Imaging for Assessment of EGCG EffectHal Chapman · PI: Fernando Martinez, MD
- RECRUITINGPhase 1NCT06230822Safety, Tolerability and Efficacy of VUM02 Injection in Treatment of Idiopathic Pulmonary Fibrosis (IPF)Wuhan Optics Valley Vcanbiopharma Co., Ltd.
- RECRUITINGN/ANCT06251687Application of Transbronchial Cryobiopsy in the Diagnosis of Progressive Pulmonary FibrosisChina-Japan Friendship Hospital
- RECRUITINGPhase 2NCT05571059Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)Cumberland Pharmaceuticals · PI: Todd Rice, MD, MSc
- RECRUITINGEarly Phase 1NCT06267183A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of SV001 in Chinese Healthy Adult Volunteers.Shanghai Synvida Biotechnology Co.,Ltd.
- RECRUITINGN/ANCT05989698Validation of the C-mo System - Cough MonitoringCough Monitoring Medical Solutions · PI: Nuno M Neuparth, PhD
- RECRUITINGPhase 3NCT05943535Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)United Therapeutics
- RECRUITINGPhase 3NCT05674994Glucocorticoids Versus Placebo for the Treatment of Acute Exacerbation of Idiopathic Pulmonary FibrosisFondation Hôpital Saint-Joseph · PI: Jean-Marc NACCACHE
- ACTIVE NOT RECRUITINGPhase 3NCT06025578A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary FibrosisBristol-Myers Squibb · PI: Bristol-Myers Squibb
- ENROLLING BY INVITATIONNCT06327360Illness Expectations in Pulmonary FibrosisFondazione Don Carlo Gnocchi Onlus
- RECRUITINGN/ANCT06304207Telehealth and Onsite Maintenance Exercise in Chronic Lung DiseaseMGH Institute of Health Professions · PI: Shweta Gore, PhD
- ACTIVE NOT RECRUITINGPhase 1NCT05195918Study of Oral Epigallocatechin-3-gallate (EGCG) in IPF PatientsHal Chapman · PI: Harold Chapman, MD
- ACTIVE NOT RECRUITINGEarly Phase 1NCT05883293Clinical Study of Allogeneic Fat Decellularized Active Protein in the Treatment of Pulmonary FibrosisShanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
- RECRUITINGNCT07373288HOXB7 and Linked Tissue and Blood Biomarkers in the Lungs of Patients With Pulmonary FibrosisUniversity of Modena and Reggio Emilia
- RECRUITINGPHASE2, PHASE3NCT06125327SC1011 Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)Guangzhou JOYO Pharma Co., Ltd
- RECRUITINGN/ANCT05842681Azithromycin in the Management of Patients With Acute Exacerbation of Idiopathic Pulmonary FibrosisAssiut University · PI: ahmad M shaddad
- RECRUITINGPhase 2NCT06189820Role of the Fibroblast Activation Protein (FAP) as Biomarker of Fibrotic Lung DiseasesErasme University Hospital
- RECRUITINGPhase 2NCT05139719A Study to Explore the Therapeutic Effect of HEC585 on Delaying Forced Vital Capacity (FVC) Decline and Tolerance in Progressive Fibrosing Interstitial Lung Disease (PF-ILD) PatientsSunshine Lake Pharma Co., Ltd.
- RECRUITINGNCT05098717End-expiratory Trans-pulmonary Pressure Guided PEEP Titration in Patients With Pulmonary Fibrosis and UIP Pattern Undergoing Mechanical VentilationUniversity of Modena and Reggio Emilia
- ACTIVE NOT RECRUITINGPhase 2NCT05570058Assess the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of RXC007 in Idiopathic Pulmonary FibrosisRedx Pharma Ltd · PI: Philip Molyneaux, MD
- ENROLLING BY INVITATIONPhase 3NCT04905693Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung DiseaseUnited Therapeutics
- RECRUITINGPhase 2NCT05389215Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPFDaewoong Pharmaceutical Co. LTD. · PI: Song
- ACTIVE NOT RECRUITINGPhase 2NCT05321420LYT-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)PureTech · PI: Camilla Graham, MD
- ACTIVE NOT RECRUITINGPhase 2NCT05241275Xenon MRI and Progressive ILDDuke University · PI: Robert M Tighe, MD
- RECRUITINGNCT05382572Pulmonary Fibrosis Foundation Community RegistryPulmonary Fibrosis Foundation · PI: Kevin R Flaherty, MD
- RECRUITINGPhase 1NCT05016817Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for IPFThe Foundation for Orthopaedics and Regenerative Medicine · PI: Chadwick Prodromos, MD
- RECRUITINGNCT05042219Effects of Pulmonary Diseases and Their Treatment on Cardiac FunctionAyham Daher
- RECRUITINGNCT05191381Immune Modulation by Exosomes in COVID-19University of Ulm · PI: Manfred Weiss, MD
- RECRUITINGN/ANCT05190211Telerehabilitation in Patients With Idiopathic Pulmonary FibrosisIstanbul Medipol University Hospital
- ACTIVE NOT RECRUITINGPHASE2, PHASE3NCT04948203Assessing the Efficacy of Sirolimus in Patients With COVID-19 Pneumonia for Prevention of Post-COVID FibrosisUniversity of Chicago · PI: Ayodeji Adegunsoye, MD, MS
- RECRUITINGPhase 3NCT04965298Treating People With Idiopathic Pulmonary Fibrosis With the Addition of LansoprazoleNorfolk and Norwich University Hospitals NHS Foundation Trust · PI: Professor Andrew Wilson
- ACTIVE NOT RECRUITINGN/ANCT02848625Yoga Effect on Quality of Life Study Among Patients with Idiopathic Pulmonary FibrosisUniversity of Washington · PI: Ganesh Raghu, MD
- ACTIVE NOT RECRUITINGNCT04564183Advancing Prevention of Pulmonary FibrosisUniversity of Colorado, Denver · PI: David Schwartz, MD
- RECRUITINGPhase 1NCT04362644Molecular Imaging Probes to Inform Heterogeneity in Idiopathic Pulmonary FibrosisUniversity of Alabama at Birmingham
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT04598919Saracatinib in the Treatment of Idiopathic Pulmonary FibrosisNational Jewish Health · PI: Gregory Downey, MD
- ACTIVE NOT RECRUITINGNCT04680832Exhaled Breath Analysis Using eNose Technology as a Biomarker for Diagnosis and Disease Progression in Fibrotic ILDErasmus Medical Center · PI: Marlies S Wijsenbeek, MD PhD
- RECRUITINGPhase 3NCT04541680Nintedanib for the Treatment of SARS-Cov-2 Induced Pulmonary FibrosisAssistance Publique - Hôpitaux de Paris
- ACTIVE NOT RECRUITINGPhase 1NCT04262167Human Autologous Lung Stem Cell Transplant for Idiopathic Pulmonary FibrosisUniversity of North Carolina, Chapel Hill · PI: Leonard Lobo, MD
- ACTIVE NOT RECRUITINGNCT04676594Genentech Validation Tool for Pulmonary FibrosisColumbia University · PI: Mary Salvatore, MD
- ACTIVE NOT RECRUITINGPhase 2NCT04071769Genentech Xenon MRI Idiopathic Pulmonary FibrosisDuke University · PI: Robert Tighe, MD
- RECRUITINGNCT04442711Cohort of IPF Patients Experiencing an ExacerbationUniversity Hospital, Gentofte, Copenhagen
- RECRUITINGNCT04304898An International Patient-led Registry in Fibrotic Interstitial Lung Diseases Using eHealth TechnologyErasmus Medical Center · PI: Marlies Wijsenbeek, MD PhD
- ACTIVE NOT RECRUITINGN/ANCT03752892Partitioned Training of Patients With Idiopathic Pulmonary FibrosisWest Park Healthcare Centre · PI: Roger S Goldstein
- ACTIVE NOT RECRUITINGNCT03457935Detection of Early Idiopathic Pulmonary FibrosisTemple University
- RECRUITINGNCT03478553The Genetics of Pulmonary FibrosisUniversity of Colorado, Denver · PI: David A Schwartz, MD
- ACTIVE NOT RECRUITINGNCT05313672Inspiratory Effort and Respiratory Mechanics in Spontaneously Breathing Patients With Acute Exacerbation of Idiopathic Pulmonary Fibrosis: a Matched Control StudyRoberto Tonelli
- ACTIVE NOT RECRUITINGNCT02755441Pulmonary Fibrosis Biomarker Cohort - a Prospective Cohort of Incident Patients With IPFNils Hoyer · PI: Nils Hoyer, MD
- ACTIVE NOT RECRUITINGNCT02772549Early Diagnosis of Pulmonary Fibrosis - Diagnostic DelayNils Hoyer
- RECRUITINGNCT04160715Korean Idiopathic Pulmonary Fibrosis RegistrySeoul National University Hospital · PI: Man Pyo Chung, MD
- RECRUITINGN/ANCT02551068High Oxygen Delivery to Preserve Exercise Capacity in Idiopathic Pulmonary Fibrosis Patients Treated With NintedanibUniversity of British Columbia · PI: Chris Ryerson, MD
- ACTIVE NOT RECRUITINGNCT02407431PaTH Clinical Data Research Network (CDRN) Idiopathic Pulmonary Fibrosis (IPF) Clinician Patient Partnership CohortUniversity of Pittsburgh · PI: Kathleen McTigue, MD